WhitTier Trust Company’s Terns Pharmaceuticals TERN Stock Holding History

WhitTier Trust Company’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-77	Closed	-$4.06K	–	1467
2026 Q1	$4.06K	Buy	+77	New	+$3.16K	﹤0.01%	1175

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WhitTier Trust Company's TERN Position: Q2 2026 in Review

WhitTier Trust Company sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 77 shares — an estimated $4.06K sold.

WhitTier Trust Company first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $4.06K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

WhitTier Trust Company reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
WhitTier Trust Company sold 77 Terns Pharmaceuticals shares in Q2 2026, an estimated $4.06K.
WhitTier Trust Company first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
WhitTier Trust Company's Terns Pharmaceuticals position peaked at $4.06K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.